IMARC Group has published a market research report titled “United States Breast Imaging Market Report by Technology (Ionizing Breast Imaging, Non-Ionizing Breast Imaging), End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others), and Region 2024-2032“, United States breast imaging market size is projected to exhibit a growth rate (CAGR) of 7.00% during 2024-2032.
The growing consciousness about breast cancer as well as the importance of early detection are the factors responsible for the growth of the United States breast imaging market. Additionally, advances in imaging technologies, such as digital mammography, 3D mammography (tomosynthesis), and magnetic resonance imaging (MRI), are enhancing the accuracy and reliability of breast cancer screenings. Moreover, the implementation of artificial intelligence in breast imaging is further revolutionizing the field, aiding radiologists in interpreting images more accurately and efficiently. Besides this, AI algorithms can assist in identifying subtle changes in breast tissue, leading to earlier and more accurate diagnoses.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-breast-imaging-market/requestsample
United States Breast Imaging Market Trends and Drivers:
Initiatives taken by government authorities and robust healthcare infrastructure are significant drivers of the breast imaging market in the United States. Programs such as NBCCEDP and the National Breast and Cervical Cancer Early Detection Program provide funding and support for breast cancer screenings, particularly for underserved populations. In addition to this, the increasing prevalence of breast cancer and the aging population are contributing to the rising demand for advanced breast imaging solutions. Public health campaigns and education efforts are raising awareness about the significance of regular breast screenings, leading to higher screening rates. Furthermore, the focus of the healthcare industry on precision medicine and personalized care is driving the adoption of advanced imaging technologies that can tailor screening and diagnostic approaches to individual patient needs, which is anticipated to drive the United States breast imaging market over the forecasted period.
Leading Companies Operating in the United States Breast Imaging Industry:
- Aurora Healthcare US Corp.
- Carestream Health Inc.
- FUJIFILM Holdings Corporation
- GE HealthCare Technologies Inc.
- Philips Healthcare
- Siemens Medical Solutions USA Inc. (Siemens AG)
Report Segmentation:
The report has segmented the market into the following categories:
Technology Insights:
- Ionizing Breast Imaging
- Mammography
- Positron Emission Tomography-Computed Tomography
- Molecular Breast Imaging
- Positron Emission Mammography
- Cone-Beam Computed Tomography
- Non-Ionizing Breast Imaging
- Breast Ultrasound
- Breast MRI
- Automated Whole-Breast Ultrasound
- Breast Thermography
- Electric Impedance Tomography
- Optical Imaging
End User Insights:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163